Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Varonis Systems
VRNS
$5.15B
| $16M | ﹤0.01% |
487,791
-60,841
| -11% | -$2.55M |
|
1377
East-West Bancorp
EWBC
$18.6B
| $16M | ﹤0.01% |
142,078
-271,606
| -66% | -$28.8M |
|
1378
Q2 Holdings
QTWO
$4.07B
| $15.9M | ﹤0.01% |
221,009
+74,588
| +51% | +$5.12M |
|
1379
Halozyme
HALO
$11.4B
| $15.9M | ﹤0.01% |
236,764
-71,459
| -23% | -$4.81M |
|
1380
Lyft
LYFT
$6.46B
| $15.9M | ﹤0.01% |
822,452
+71,701
| +10% | +$1.49M |
|
1381
Joby Aviation
JOBY
$8.22B
| $15.9M | ﹤0.01% |
1,206,169
+520,711
| +76% | +$7.99M |
|
1382
Prosperity Bancshares
PB
$8.96B
| $15.8M | ﹤0.01% |
228,789
-167,785
| -42% | -$11.3M |
|
1383
Alkermes
ALKS
$8.31B
| $15.8M | ﹤0.01% |
565,033
+8,382
| +2% | +$251K |
|
1384
NCR Atleos
NATL
$3.47B
| $15.7M | ﹤0.01% |
413,210
+8,516
| +2% | +$319K |
|
1385
Petrobras
PBR
$116B
| $15.7M | ﹤0.01% |
1,326,699
+709,137
| +115% | +$8.66M |
|
1386
Caesars Entertainment
CZR
$6.05B
| $15.7M | ﹤0.01% |
672,010
-193,869
| -22% | -$4.36M |
|
1387
SolarEdge
SEDG
$1.99B
| $15.7M | ﹤0.01% |
544,141
-213,045
| -28% | -$7.43M |
|
|
SNDK
1388
CALL
Sandisk
SNDK
$225B
| $15.7M | ﹤0.01% |
66,000
| – | – |
|
1389
Antero Resources
AR
$11.3B
| $15.7M | ﹤0.01% |
454,631
-104,654
| -19% | -$3.54M |
|
1390
SouthState Bank Corp
SSB
$10.8B
| $15.7M | ﹤0.01% |
166,465
-17,005
| -9% | -$1.58M |
|
1391
Abercrombie & Fitch
ANF
$4.89B
| $15.6M | ﹤0.01% |
124,277
-145,528
| -54% | -$12.7M |
|
1392
Knife River
KNF
$3.8B
| $15.6M | ﹤0.01% |
222,303
+89,179
| +67% | +$6.26M |
|
|
VISN
1393
Vistance Networks Inc
VISN
$2.67B
| $15.6M | ﹤0.01% |
860,485
+548,064
| +175% | +$9.45M |
|
1394
Marathon Digital Holdings
MARA
$3.6B
| $15.5M | ﹤0.01% |
1,730,400
+580,026
| +50% | +$8.56M |
|
1395
Qualys
QLYS
$6.71B
| $15.5M | ﹤0.01% |
116,695
-61,158
| -34% | -$8.41M |
|
1396
US Foods
USFD
$23.8B
| $15.5M | ﹤0.01% |
205,553
-100,655
| -33% | -$7.56M |
|
1397
Ormat Technologies
ORA
$7B
| $15.4M | ﹤0.01% |
139,475
-2,961
| -2% | -$324K |
|
1398
Magna International
MGA
$18.7B
| $15.4M | ﹤0.01% |
288,602
+9,908
| +4% | +$484K |
|
|
SF
1399
Stifel
SF
$12.9B
| $15.4M | ﹤0.01% |
184,041
-234,320
| -56% | -$18.7M |
|
1400
Agree Realty
ADC
$9.31B
| $15.4M | ﹤0.01% |
213,289
-17,121
| -7% | -$1.25M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.